The Ethics of Choosing Children || Gift and Beneficence
- 作者Reader, Simon
- 文件大小193.84KB
- 发表时间2017
- DOI10.1007/978-3-319-59864-2_2
- 页码29-54
[Topics in Medicinal Chemistry] || Inhibitors of Histidinol DehydrogenaseKöhler, Stephan · 2016
[Topics in Medicinal Chemistry] || Small Molecule Inhibitors of ALKHatcher, John M. · 2017
[Topics in Medicinal Chemistry] || Inhibitors of the Kynurenine PathwayRöhrig, Ute F. · 2017
[Topics in Medicinal Chemistry] || Structure-Based Design of Epigenetic InhibitorsRobaa, Dina · 2019
[Topics in Medicinal Chemistry] || Inhibitors of JmjC-Containing Histone DemethylasesWright, Miranda · 2019
[Topics in Medicinal Chemistry] || Inhibitors of Vascular Endothelial Growth Factor ReceptorHarris, Philip A. · 2017
[Topics in Medicinal Chemistry] || Evolution of HCV NS4B InhibitorsManfroni, Giuseppe · 2019
ChemInform Abstract: Synthesis of Highly Substituted Symmetrical 1,3-Dienes via Organocuprate Oxidation.Sarah J. Aves; Kieron M. G. O'Connell; Kurt G. Pike; David R. Spring · 2012
ChemInform Abstract: Synthesis of 3-Substituted 2-Aminopyridines via Displacement of 3-Fluoro-2-nitropyridine.Culshaw, Janet D.; Eden, Jonathan M.; Ford, Susannah J.; Hayter, Barry; Perkins, David R.; Pike, Kurt G. · ChemInform · 2012
ChemInform Abstract: Synthesis of Highly Substituted Symmetrical 1,3-Dienes via Tandem Carbocupration and Organocuprate Oxidation.Sarah J. Aves; Kurt G. Pike; David R. Spring · 2011
Design of a potent, soluble glucokinase activator with excellent in vivo efficacyDarren McKerrecher; Joanne V. Allen; Peter W.R. Caulkett; Craig S. Donald; Mark L. Fenwick; Emma Grange; Keith M. Johnson; Craig Johnstone; Clifford D. Jones; Kurt G. Pike; John W. Rayner; Rolf P. Walker · 2006
Design of a potent, soluble glucokinase activator with increased pharmacokinetic half-lifeKurt G. Pike; Joanne V. Allen; Peter W.R. Caulkett; David S. Clarke; Craig S. Donald; Mark L. Fenwick; Keith M. Johnson; Craig Johnstone; Darren McKerrecher; John W. Rayner; Rolf P. Walker; Ingrid Wilson · 2011
A Novel Series of p38 MAP Kinase Inhibitors for the Potential Treatment of Rheumatoid Arthritis.Dearg S. Brown; Andrew J. Belfield; George R. Brown; Douglas Campbell; Alan Foubister; David J. Masters; Kurt G. Pike; Wendy L. Snelson; Stuart L. Wells · 2005
A novel series of p38 MAP kinase inhibitors for the potential treatment of rheumatoid arthritisDearg S. Brown; Andrew J. Belfield; George R. Brown; Douglas Campbell; Alan Foubister; David J. Masters; Kurt G. Pike; Wendy L. Snelson; Stuart L. Wells · 2004